|
2001 Conference Publication Relationship of hypertension severity to hybrid gene crossover point in familial hyperaldosteronism type 1 (FH-1)Stowasser, M., Gunasekera, T. G. and Gordon, R. D. (2001). Relationship of hypertension severity to hybrid gene crossover point in familial hyperaldosteronism type 1 (FH-1). Eleventh European Meeting on Hypertension, Milan, Italy, 15-19 June, 2001. Philadelphia, USA: Lippincott Williams & Wilkins. |
|
2001 Journal Article Familial hyperaldosteronismStowasser, Michael and Gordon, Richard D. (2001). Familial hyperaldosteronism. Journal of Steroid Biochemistry And Molecular Biology, 78 (3), 215-229. doi: 10.1016/S0960-0760(01)00097-8 |
|
2001 Conference Publication Primary aldosteronism (PAL) at Princess Alexandra Hospital: Correcting KaplanStowasser, M., Gunasekera, T. G., Cowley, D., Ward, G. and Smithers, B. M. (2001). Primary aldosteronism (PAL) at Princess Alexandra Hospital: Correcting Kaplan. 23rd Annual Scientific Meeting, Melbourne, 13-14 Dec 2001. Australia: High Blood Pressure Research Council of Aust Inc. |
|
2001 Journal Article Primary aldosteronism: Rare bird or common cause of secondary hypertension?Stowasser, M. (2001). Primary aldosteronism: Rare bird or common cause of secondary hypertension?. Current Hypertension Reports, 3 (3), 230-239. |
|
2001 Journal Article Familial varieties of primary aldosteronismStowasser, M, Gunasekera, TG and Gordon, RD (2001). Familial varieties of primary aldosteronism. Clinical And Experimental Pharmacology And Physiology, 28 (12), 1087-1090. doi: 10.1046/j.1440-1681.2001.03574.x |
|
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52. |
|
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, Richard D. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. |
|
2000 Journal Article Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasiaBofinger, A., Hawley, C., Fisher, P., Daunt, N., Stowasser, M. and Gordon, R. (2000). Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia. Journal of Human Hypertension, 14 (2), 91-94. doi: 10.1038/sj.jhh.1000935 |
|
2000 Journal Article Primary aldosteronism: learning from the study of familial varietiesStowasser, M and Gordon, RD (2000). Primary aldosteronism: learning from the study of familial varieties. Journal of Hypertension, 18 (9), 1165-1176. doi: 10.1097/00004872-200018090-00002 |
|
2000 Conference Publication Clinical, biomedical and radiological overlap between familial hyperaldosteronism type I and II: importance of genetic testingStowasser, M., Taylor, W., Daunt, N., Slater, G., Rossetti, T. and Gordon, R. D. (2000). Clinical, biomedical and radiological overlap between familial hyperaldosteronism type I and II: importance of genetic testing. Abstracts of the 18th Scientific Meeting of the Int. Society of Hypertension, Chicago, USA, 20-24 Aug 2000. Philadelphia, USA: Lippincott Williams & Wilkins. |
|
2000 Conference Publication Clinical, biochemical and radiological overlap between familial hyperaldosteronism types I and II: Importance of genetic testingStowasser, M, Taylor, W, Daunt, N, Slater, G, Rossetti, T and Gordon, R (2000). Clinical, biochemical and radiological overlap between familial hyperaldosteronism types I and II: Importance of genetic testing. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2000 Journal Article Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1pBenn, DE, Dwight, T, Richardson, AL, Delbridge, L, Bambach, CP, Stowasser, M, Gordon, RD, Marsh, DJ and Robinson, BG (2000). Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Research, 60 (24), 7048-7051. |
|
2000 Journal Article How common is adrenal-based mineralocortoid hypertension?Stowasser, M. (2000). How common is adrenal-based mineralocortoid hypertension?. Current Opinion in Endocrinology & Diabetes, 7 (3), 143-150. doi: 10.1097/00060793-200006000-00007 |
|
2000 Conference Publication Angiotensin II (AngII) receptors in AngII-responsive (AngII-R) and angII-unresponsive (AngII-U) aldosterone-producing adenoma (APA)Stowasser, M, Zhuo, J, Ohishi, M, Mendelsohn, F and Gordon, R (2000). Angiotensin II (AngII) receptors in AngII-responsive (AngII-R) and angII-unresponsive (AngII-U) aldosterone-producing adenoma (APA). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2000 Journal Article A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)Lafferty, Antony R., Torpy, David J., Stowasser, Michael, Taymans, Susan E., Lin, Jing Ping, Huggard, Philip, Gordon, Richard D. and Stratakis, Constantine A. (2000). A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). Journal of Medical Genetics, 37 (11), 831-835. doi: 10.1136/jmg.37.11.831 |
|
2000 Journal Article Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247 |
|
2000 Conference Publication Angiotensin II (Angll) receptors in angll-response (Angll-R) and angll-unresponsive (Angll-U) aldosterone-producing adenoma (APA)Stowasser, M., Zhuo, J., Ohishi, M., Mendelsohn, F. and Gordon, R. D. (2000). Angiotensin II (Angll) receptors in angll-response (Angll-R) and angll-unresponsive (Angll-U) aldosterone-producing adenoma (APA). 18th Scientific Meeting of the Int. Society of Hypertension, Chicago, USA, 20-24 Aug 2000. Philadelphia, USA: Lippincott Williams & Wilkins. |
|
2000 Journal Article Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Treatment of familial hyperaldosteronism type I: Only partial suppression of adrenocorticotropin required to correct hypertension. Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jcem.85.9.6834 |
|
2000 Journal Article Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbanceStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R. and Gordon, R. D. (2000). Severity of hypertension in familial hyperaldosteronism type I: Relationship to gender and degree of biochemical disturbance. The Journal of Clinical Endocrinology and Metabolism, 85 (6), 2160-2166. doi: 10.1210/jc.85.6.2160 |
|
2000 Journal Article Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertensionStowasser, M, Bachmann, AW and Gordon, RD (2000). Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension. The Journal of Clinical Endocrinology and Metabolism, 85 (9), 3313-3318. doi: 10.1210/jc.85.9.3313 |
